‌

7669

Eli Lilly agreed to pay the state 18.5 million to settle allegation of off-label marketing of Zyprexa for non-FDA approved uses such as dementia, aggression, hostility, depression and generalized sleep disorders in adults. It was further alleged that Eli Lilly improperly marketed the drug for use by children.

Last sale

Holder

0xbd...e518

HODLed for

2 years

Fees

There were no sales for this token

Details

Created

Nov 17th, 2022, 14:49

Blockchain

ETH

Storage

decentralized

Token standart

ERC-721

Metadata

View

Unlockable content

Rarity

Rarity score

70.11%

Rarity rank

# 759 / 10000

Trait count

What is the value?

Price

Sales

Sales (All)

N/A

Avg collection sales (All)

N/A

Difference

N/A

Collectible last sale price

Collection avg price (All)

Difference

N/A

Collectible last sale price

Collection min price (All)

Difference

N/A

Successful royalty payments

Skipped royalty payments

Difference

N/A

Activity history

Processing data. Please, come back later.

‌

Overall Score

Critical Risk

‌

Critical Risks

‌

Medium Risks

‌

Low Risks

Details

‌

Collection Sales

0 sales per last month

‌

Metadata Storage

Decentralized storage

‌

Creator Royalty

7.5%

‌

Artifact Storage

Decentralized storage

‌

Unique Owners

Collection tokens10000 tokens

Unique Owners453 / 4.53%

‌

External Contract

Custom contract

‌

Token Type

ERC-721

‌

Editable Metadata

Not editable metadata stored on ipfs or blockchain

‌

Suspicious Sales

0 potential sales

‌

Missed Royalty Payments

0% missed royalty fee

‌

Copymints

The original collection.

Found 0 similar collections

More Risks and Alerts parameters coming soon